It is not difficult to understand why Congress has crafted a health care bill that avoids making any huge changes to the basic infrastructure of the health care industry . According to The New York Times , citing the Center for Responsive Politics , the health care and insurance industry spent at least 648 million on lobbying in 2009 and 20 percent of the year end reports were not in yet . Pharmaceutical companies spent about 245 million , which the Times said was more than any other single industry has ever spent lobbying on behalf of any issue .
